The same study also reported an increase in level of MMP-3 in the sera of patients with increasing stage of BC (but still not significantly different from healthy control), but since all of our patients were in stage I of BC, we were unable to determine whether a similar relationship could be observed for patients with Luminal A and B HER2-negative subtypes of BC. This evidence concerns the gene ERBB2 and breast cancer.